Cargando…

Antifungal Properties of Hydrazine-Based Compounds against Candida albicans

Candida albicans, an opportunistic yeast, is the most common cause of fungal infection. In the past decade, there has been an increase in C. albicans resistance to existing antifungal drugs, which has necessitated the development of new antifungal agents. In the present study, screening 60 compounds...

Descripción completa

Detalles Bibliográficos
Autores principales:	Camaioni, Louis, Lambert, Dylan, Sendid, Boualem, Billamboz, Muriel, Jawhara, Samir
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10295702/ https://www.ncbi.nlm.nih.gov/pubmed/37370362 http://dx.doi.org/10.3390/antibiotics12061043

Ejemplares similares

Natural Compounds with Antifungal Properties against Candida albicans and Identification of Hinokitiol as a Promising Antifungal Drug
por: Camaioni, Louis, et al.
Publicado: (2023)

Two New Compounds Containing Pyridinone or Triazine Heterocycles Have Antifungal Properties against Candida albicans
por: Mena, Laura, et al.
Publicado: (2022)

A Small Aromatic Compound Has Antifungal Properties and Potential Anti-Inflammatory Effects against Intestinal Inflammation
por: Bortolus, Clovis, et al.
Publicado: (2019)

Promising Drug Candidates and New Strategies for Fighting against the Emerging Superbug Candida auris
por: Billamboz, Muriel, et al.
Publicado: (2021)

Intravenous Immunoglobulin Therapy Eliminates Candida albicans and Maintains Intestinal Homeostasis in a Murine Model of Dextran Sulfate Sodium-Induced Colitis
por: Charlet, Rogatien, et al.
Publicado: (2019)

Oleic Acid and Palmitic Acid from Bacteroides thetaiotaomicron and Lactobacillus johnsonii Exhibit Anti-Inflammatory and Antifungal Properties
por: Charlet, Rogatien, et al.
Publicado: (2022)

Short term Candida albicans colonization reduces Pseudomonas aeruginosa-related lung injury and bacterial burden in a murine model
por: Ader, Florence, et al.
Publicado: (2011)

Role of TLR1, TLR2 and TLR6 in the modulation of intestinal inflammation and Candida albicans elimination
por: Choteau, Laura, et al.
Publicado: (2017)

A decrease in anaerobic bacteria promotes Candida glabrata overgrowth while β-glucan treatment restores the gut microbiota and attenuates colitis
por: Charlet, Rogatien, et al.
Publicado: (2018)

Anti-Malassezia Drug Candidates Based on Virulence Factors of Malassezia-Associated Diseases
por: Billamboz, Muriel, et al.
Publicado: (2023)

Remodeling of the Candida glabrata cell wall in the gastrointestinal tract affects the gut microbiota and the immune response
por: Charlet, Rogatien, et al.
Publicado: (2018)

Dissection of the anti-Candida albicans mannan immune response using synthetic oligomannosides reveals unique properties of β-1,2 mannotriose protective epitopes
por: Sendid, Boualem, et al.
Publicado: (2021)

Bacteroides thetaiotaomicron and Lactobacillus johnsonii modulate intestinal inflammation and eliminate fungi via enzymatic hydrolysis of the fungal cell wall
por: Charlet, Rogatien, et al.
Publicado: (2020)

The newly synthesized thiazole derivatives as potential antifungal compounds against Candida albicans
por: Biernasiuk, Anna, et al.
Publicado: (2021)

Antifungal compounds of Chinese prickly ash against drug-resistant Candida albicans
por: Ma, Dan-Yu, et al.
Publicado: (2022)

How Gut Bacterial Dysbiosis Can Promote Candida albicans Overgrowth during Colonic Inflammation
por: Jawhara, Samir
Publicado: (2022)

Antifungal activity of hypocrellin compounds and their synergistic effects with antimicrobial agents against Candida albicans
por: Song, Shihao, et al.
Publicado: (2020)

Attempts to Access a Series of Pyrazoles Lead to New Hydrazones with Antifungal Potential against Candida species including Azole-Resistant Strains
por: Negru, Georgiana, et al.
Publicado: (2021)

In Vitro Antifungal Activity of Equol against Candida albicans
por: Lee, Jeong Ah, et al.
Publicado: (2010)

Liquid and vapour-phase antifungal activities of essential oils against Candida albicans and non-albicans Candida
por: Mandras, Narcisa, et al.
Publicado: (2016)

H89 Treatment Reduces Intestinal Inflammation and Candida albicans Overgrowth in Mice
por: Dumortier, Corentin, et al.
Publicado: (2020)

Antibodies as Models and Tools to Decipher Candida albicans Pathogenic Development: Review about a Unique Monoclonal Antibody Reacting with Immunomodulatory Adhesins
por: Leroy, Jordan, et al.
Publicado: (2023)

Antifungal Activity of Oleuropein against Candida albicans—The In Vitro Study
por: Zorić, Nataša, et al.
Publicado: (2016)

Antifungal Activity of Coumarin Against Candida albicans Is Related to Apoptosis
por: Jia, Chang, et al.
Publicado: (2019)

Photodynamic Antifungal Activity of Hypocrellin A Against Candida albicans
por: Yang, Yijia, et al.
Publicado: (2019)

Azole Antifungal Resistance in Candida albicans and Emerging Non-albicans Candida Species
por: Whaley, Sarah G., et al.
Publicado: (2017)

How Fungal Glycans Modulate Platelet Activation via Toll-Like Receptors Contributing to the Escape of Candida albicans from the Immune Response
por: Jawhara, Samir
Publicado: (2020)

Promising Antifungal Targets Against Candida albicans Based on Ion Homeostasis
por: Li, Yiman, et al.
Publicado: (2018)

Humoral Immunity Links Candida albicans Infection and Celiac Disease
por: Corouge, Marion, et al.
Publicado: (2015)

De-escalation of antifungal treatment in critically ill patients with suspected invasive Candida infection: incidence, associated factors, and safety
por: Jaffal, Karim, et al.
Publicado: (2018)

A New Antifungal Agent (4-phenyl-1, 3-thiazol-2-yl) Hydrazine Induces Oxidative Damage in Candida albicans
por: Lv, Quan-Zhen, et al.
Publicado: (2020)

Adherent invasive Escherichia coli (AIEC) strain LF82, but not Candida albicans, plays a profibrogenic role in the intestine
por: Chokr, Dina, et al.
Publicado: (2021)

Synthetic arylquinuclidine derivatives exhibit antifungal activity against Candida albicans, Candida tropicalis and Candida parapsilopsis
por: Ishida, Kelly, et al.
Publicado: (2011)

In vitro antifungal potency of the moronecidin-like peptide against Candida albicans, Candida glabrata, and Candida tropicalis
por: Amirrajab, Nasrin, et al.
Publicado: (2023)

Evaluation of Antifungal Activity and Mechanism of Action of Citral against Candida albicans
por: Leite, Maria Clerya Alvino, et al.
Publicado: (2014)

In vitro evaluation of antifungal activity of monolaurin against Candida albicans biofilms
por: Seleem, Dalia, et al.
Publicado: (2016)

Antifungal effect of calcium enriched mixture cement against Candida albicans
por: Kangarlou, Ali, et al.
Publicado: (2009)

Antifungal Activity of Commercial Essential Oils and Biocides against Candida Albicans
por: Serra, Elisa, et al.
Publicado: (2018)

Antifungal Efficacy of Spice Extracts against Candida albicans: An in vitro study
por: Latti, Pooja, et al.
Publicado: (2019)

Antifungal activity of MAF-1A peptide against Candida albicans
por: Cheng, Rong, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_66vkmaaerjujclo9bj9vmgvgct